Polynuclear iron(III)-oxyhydroxide (pn-FeOOH) (Velphoro®)

Assessment Status Rapid Review Complete
Drug Polynuclear iron(III)-oxyhydroxide (pn-FeOOH)
Brand Velphoro®
Indication Is indicated for the control of serum phosphorus levels in adult chronic kidney disease (CKD) patients on haemodialysis (HD) or peritoneal dialysis (PD). Rapid Review
Assessment Process
Rapid review commissioned 12/09/2014
Rapid review completed 08/10/2014
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended